Literature DB >> 24463691

ACOG Practice Bulletin No. 141: management of menopausal symptoms.

.   

Abstract

Vasomotor and vaginal symptoms are cardinal symptoms of menopause. Vasomotor symptoms can be particularly troubling to women and are the most commonly reported menopausal symptoms, with a reported prevalence of 50-82% among U.S. women who experience natural menopause (1, 2). The occurrence of vasomotor symptoms increases during the transition to menopause and peaks approximately 1 year after the final menstrual period (3-5). The purpose of this document is to provide evidence-based guidelines for the treatment of vasomotor and vaginal symptoms related to natural and surgical menopause. (Treatment of menopausal symptoms in cancer survivors is discussed in the American College of Obstetricians and Gynecologists' Practice Bulletin Number 126, Management of Gynecologic Issues in Women With Breast Cancer.).

Entities:  

Mesh:

Year:  2014        PMID: 24463691     DOI: 10.1097/01.AOG.0000441353.20693.78

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  55 in total

Review 1.  Perimenopause: From Research to Practice.

Authors:  Nanette Santoro
Journal:  J Womens Health (Larchmt)       Date:  2015-12-10       Impact factor: 2.681

2.  Anxiety as a risk factor for menopausal hot flashes: evidence from the Penn Ovarian Aging cohort.

Authors:  Ellen W Freeman; Mary D Sammel
Journal:  Menopause       Date:  2016-09       Impact factor: 2.953

Review 3.  Menopausal Symptoms and Their Management.

Authors:  Nanette Santoro; C Neill Epperson; Sarah B Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09       Impact factor: 4.741

Review 4.  The etiology and management of recurrent urinary tract infections in postmenopausal women.

Authors:  Carrie Jung; Linda Brubaker
Journal:  Climacteric       Date:  2019-01-09       Impact factor: 3.005

Review 5.  Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Authors:  Nancy E Avis; Sybil L Crawford; Robin Green
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

6.  Long- but not short-term estradiol treatment induces renal damage in midlife ovariectomized Long-Evans rats.

Authors:  Margaret A Zimmerman; Dillion D Hutson; Emma H Trimmer; Shreya N Kashyap; Jennifer L Duong; Brennah Murphy; Elin M Grissom; Jill M Daniel; Sarah H Lindsey
Journal:  Am J Physiol Renal Physiol       Date:  2016-11-09

7.  A comparison of antibiotic prophylaxis regimens to decrease the risk of post-procedure urinary tract infection after onabotulinum toxin A injection.

Authors:  Jennifer A Bickhaus; Monique Vaughan; Tracy Truong; Yi-Ju Li; Nazema Y Siddiqui
Journal:  Int Urogynecol J       Date:  2020-01-27       Impact factor: 2.894

8.  Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.

Authors:  Shilpa N Bhupathiraju; Francine Grodstein; Meir J Stampfer; Walter C Willett; Carolyn J Crandall; Jan L Shifren; JoAnn E Manson
Journal:  Menopause       Date:  2018-12-17       Impact factor: 2.953

Review 9.  Improving vasomotor symptoms; psychological symptoms; and health-related quality of life in peri- or post-menopausal women through yoga: An umbrella systematic review and meta-analysis.

Authors:  M Shepherd-Banigan; K M Goldstein; R R Coeytaux; J R McDuffie; A P Goode; A S Kosinski; M G Van Noord; D Befus; S Adam; V Masilamani; A Nagi; J W Williams
Journal:  Complement Ther Med       Date:  2017-08-24       Impact factor: 2.446

10.  Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.

Authors:  Sybil L Crawford; Carolyn J Crandall; Carol A Derby; Samar R El Khoudary; L Elaine Waetjen; Mary Fischer; Hadine Joffe
Journal:  Menopause       Date:  2018-12-21       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.